華大智造(688114.SH)澄清:作為基因測序行業上游設備提供商 業務環節不涉及數據收集行為
格隆匯1月28日丨華大智造(688114.SH)公佈澄清公吿,2024年1月26日,獲悉,在一項近日美國方面提出的BIOSECURE Act草案中,華大智造被提及。公司注意到,目前該草案尚處於提案階段,且對於公司的指控存在多處事實錯誤,後續可能被修改或終止,能否形成法律尚存在較大不確定性。
公司自成立以來,一直秉承“創新智造引領生命科技”的理念,致力於成為 “生命科技核心工具締造者”,通過深化平台應用賦能客户實現更多“讀、寫、存”
的創新突破和應用場景擴容。在發展過程中,公司嚴格遵守運營市場所在地的各項法律法規,高度關注數據安全和隱私保護。作為基因測序行業上游設備提供商,公司業務環節不涉及數據收集行為,且客户基於公司測序平台所產生的數據均由客户自行收集、存儲、處理及管控。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.